About Mark Joing
Form D filings for Marea Therapeutics in 2024 list Mark Joing as executive officer.
Mark Joing first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Mark Joing in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Mark Joing works with at each company, as listed on that company's latest Form D.
Marea Therapeutics, Inc. · Form D, Jun 24, 2024
JT
Jeff Tong
Director
CG
Christine Garrett
Executive officer
JL
Josh Lehrer
Chief Executive Officer and President, director
EW
Ethan Weiss
Executive officer
AR
Aaron Royston
Director
CM
Caitlin Murray
Executive officer
JC
Jung Choi
Director
MK
Maha Katabi
Director
TL
Ted Love
Director
AB
Antoine Boulanger
Director
CG
Chris Garabedian
Director